IndiaOne Finance - Company Dashboard

Governance Classic Home

Kilitch Drugs India LtdPharmaceuticalsINE729D01010Consolidated₹193.80+2.70 (+1.41%)Jun-26

Valuation

Market Cap₹669.34 Cr

TTM PE21.76x

Forward PE22.72x

PEG-17.69

Book Value₹79.99

P/B2.39x

TTM EPS₹8.80

Fwd EPS₹8.43

TTM Revenue₹237.22 Cr

TTM PAT₹29.21 Cr

TTM EBITDA₹36.28 Cr

TTM EBIT₹32.41 Cr

Last Qtr PAT₹1.97 Cr

Last Qtr EBITDA₹2.94 Cr

Last Qtr EBIT₹1.85 Cr

Profitability

ROE10.45%

ROCE11.94%

TTM NPM12.31%

TTM EBITDA %15.29%

Curr OPM4.12%

Last OPM16.51%

Curr NPM—

Last NPM—

Curr EPS₹0.83

Last EPS₹4.24

Balance sheet

Equity₹34.96 Cr

Reserve₹244.69 Cr

Total Debt₹88.71 Cr

D/E0.32x

Interest %44.67%

Curr Interest₹0.88 Cr

Price / range

Close₹191.45

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+1.47%

1W+3.69%

1M+18.35%

3M+6.28%

6M+21.50%

1Y+5.38%

2Y+2.99%

3Y+70.06%

5Y+117.98%

Diwali-46.65%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	40.91+19.9%	71.97	44.67	37.81	34.12	188.57
Other Income	3.55	1.14	1.61	7.61	3.50	13.85
Total Income	44.46+18.2%	73.11	46.28	45.42	37.62	202.42
Interest	0.49	0.58	0.60	0.68	0.59	2.44
Expenditure	-37.51-18.6%	-53.78	-40.11	-35.35	-31.64	-160.87
PBDT	0	0	0	0	0	0
EBITDA	4.65+30.3%	19.47	5.72	3.67	3.57	32.43
Depreciation	-0.76	-0.70	-0.56	-0.53	-0.50	-2.29
EBIT	3.89+26.7%	18.77	5.16	3.14	3.07	30.14
PBT	6.95+16.2%	19.33	6.17	10.07	5.98	41.55
Tax	-1.90	-5.33	-1.28	-1.36	-1.19	-9.15
Equity	34.96	34.96	0	0	16.08	34.96
OPM	15.63	26.44	13.81	26.64	15.90	20.53
Net Profit	5.05+5.4%	14	4.89	8.72	4.79	32.40
NPM	11.36	19.15	10.95	23.05	12.73	16.01
EPS	1.45-51.3%	4.08	2.74	5.27	2.98	9.57

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	188.57+3.8%	181.59+38.0%	131.60+11.7%	117.78+12.0%	105.16+50.2%	70.02
Other Income	13.85	13.72	6.19	4.60	4.56	4.19
Total Income	202.42+3.6%	195.30+41.7%	137.79+12.6%	122.38+11.5%	109.72+47.9%	74.21
Expenditure	-160.87-4.0%	-154.61-35.1%	-114.43-11.2%	-102.93-7.5%	-95.79-43.6%	-66.70
Interest	-2.44	-2.13	-1.91	-0.99	-0.66	-0.75
PBDT	0	0	0	0	0	0
EBITDA	32.43+5.1%	30.85+51.8%	20.32+18.3%	17.18+56.3%	10.99+110.9%	5.21
Depreciation	-2.29	-1.74	-1.24	-1.34	-0.96	-1.14
EBIT	30.14+3.5%	29.11+52.6%	19.08+20.5%	15.84+57.9%	10.03+146.4%	4.07
PBT	41.55+2.1%	40.69+74.3%	23.35+20.1%	19.45+39.6%	13.93+85.5%	7.51
Tax	-9.15	-9.53	-5.78	-3.73	-3.40	-1.35
Equity	34.96	16.08	0	0	0	0
OPM (%)	20.53	20.83	17.00	16.00	13.00	10.00
Net Profit	32.40+4.0%	31.16+77.3%	17.57+11.8%	15.72+49.3%	10.53+70.9%	6.16
NPM (%)	16.01	15.95	13.00	13.00	10.00	8.00
EPS (Rs)	9.57-50.6%	19.37+75.6%	11.03+9.3%	10.09+49.3%	6.76+69.8%	3.98
CEPS	9.57	19.37	11.03	10.09	6.76	3.98

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	44.88+4.0%	89.60	53.81	48.93	43.14	235.48
Other Income	2.90	0.49	1.53	6.66	2.56	11.24
Total Income	47.78+4.6%	90.10	55.34	55.59	45.70	246.71
Interest	0.88	1.44	1.15	1.44	1.53	5.56
Expenditure	-43.91-3.9%	-69.88	-49.74	-46.19	-42.25	-208.06
PBDT	0	0	0	0	0	0
EBITDA	2.94-9.8%	22.14	6.16	5.04	3.26	36.60
Depreciation	-1.09	-0.98	-0.94	-0.86	-0.84	-3.62
EBIT	1.85-23.6%	21.16	5.22	4.18	2.42	32.98
PBT	3.86+11.9%	20.21	5.60	9.40	3.45	38.65
Tax	-1.90	-5.33	-1.28	-1.36	-1.19	-9.15
Equity	34.96	34.96	0	0	16.08	34.96
OPM	8.08	22.43	10.11	16.91	7.55	15.67
Net Profit	1.97-12.8%	14.88	4.32	8.04	2.26	29.50
NPM	4.12	16.51	7.80	14.46	4.95	11.96
EPS	0.83-55.9%	4.24	2.50	4.97	1.88	8.91

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	235.47+18.7%	198.32+28.5%	154.37+10.6%	139.60+22.2%	114.23+66.7%	68.52
Other Income	11.24	11.16	4.48	2.92	2.91	2.67
Total Income	246.71+17.8%	209.48+31.9%	158.85+11.5%	142.52+21.7%	117.14+64.5%	71.19
Expenditure	-208.06-18.9%	-175-25.4%	-139.50-6.9%	-130.50-21.4%	-107.53-62.8%	-66.07
Interest	-5.56	-5.04	-5.93	-4.92	-1.20	-0.75
PBDT	0	0	0	0	0	0
EBITDA	36.59+16.3%	31.47+30.3%	24.15+37.5%	17.57+69.4%	10.37+99.8%	5.19
Depreciation	-3.62	-3.11	-3.35	-3.55	-2.47	-1.99
EBIT	32.97+16.3%	28.36+36.3%	20.80+48.4%	14.02+77.5%	7.90+146.9%	3.20
PBT	38.65+12.1%	34.47+78.0%	19.36+61.2%	12.01+25.0%	9.61+87.7%	5.12
Tax	-9.15	-9.53	-5.78	-3.73	-3.40	-1.35
Equity	34.96	16.08	0	0	0	0
OPM (%)	15.67	16.46	12.18	8.43	8.21	7.19
Net Profit	29.50+18.3%	24.94+83.7%	13.58+64.0%	8.28+33.3%	6.21+64.7%	3.77
NPM (%)	11.96	11.91	8.55	5.81	5.30	5.29
EPS (Rs)	8.91-46.3%	16.60+81.0%	9.17+36.7%	6.71+41.9%	4.73+99.6%	2.37
CEPS	8.91	16.60	9.17	6.71	4.73	2.37

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2019	Final Dividend	0.5	20 Sep 2019
2018	Final Dividend	0.5	18 Sep 2018
	Special Dividend	30	24 Sep 2012
2011	Final Dividend	1	18 Aug 2011
2010	Final Dividend	1	14 Oct 2010
2009	Final Dividend	1	10 Sep 2009
2008	Final Dividend	1	10 Sep 2008

Bonus

Year	Ratio	Ex-Date
2026	1:1	24 Mar 2026

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split